NDC 51672-4245-01 - Enalapril Maleate
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 51672-4245
- Requested NDC
- 51672-4245-01
- Package NDCs from labels
- 51672-4245-1, 51672-4245-3, 51672-4245-01
- Manufacturer
- REMEDYREPACK INC.
- Effective date
- 2026-09-01
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Enalapril Maleate Tablets, USP | REMEDYREPACK INC. | 2026-09-01 | HUMAN PRESCRIPTION DRUG LABEL |
| Enalapril Maleate - Bryant Ranch Prepack | Bryant Ranch Prepack | 2026-08-24 | HUMAN PRESCRIPTION DRUG LABEL |
| Enalapril Maleate Tablets, USP | Golden State Medical Supply, Inc. | 2026-07-28 | HUMAN PRESCRIPTION DRUG LABEL |
| Enalapril Maleate Tablets, USP | Sun Pharmaceutical Industries, Inc. | Taro Pharmaceuticals Industries Ltd. | 2026-07-14 | HUMAN PRESCRIPTION DRUG LABEL |
| Enalapril Maleate - A-S Medication Solutions | A-S Medication Solutions | 2023-10-02 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 51672-4245-1 | Enalapril Maleate | 100 in 1 BOTTLE | TABLET | 100 | 13 | |
| 51672-4245-3 | Enalapril Maleate | 1000 in 1 BOTTLE | TABLET | 1000 | 13 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 51672-4245 | ENALAPRIL MALEATE TABLET [TARO PHARMACEUTICALS U.S.A., INC.] | 13 | Current NDC, 2 package rows | 20230728_f103b9f9-e081-419d-a2d8-b86acda834dd.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 51672-4245-1 | EA - Each | 51672-4245 | 4783b04f-762e-466c-b4ab-652d8e12ddeb | 1 | 2023-10-16 |
| 51672-4245-3 | EA - Each | 51672-4245 | ed82a21e-f396-472f-886f-b1bbea41b04d | 1 | 2023-10-16 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| Enalapril Maleate | ACTIVE INGREDIENT | 9O25354EPJ | ENALAPRIL MALEATE TABLET [TARO PHARMACEUTICALS U.S.A., INC.] | 6 | |
| Enalaprilat Anhydrous | ACTIVE MOIETY | Q508Q118JM | ENALAPRIL MALEATE TABLET [TARO PHARMACEUTICALS U.S.A., INC.] | 6 | |
| Ferric Oxide Red | INACTIVE INGREDIENT | 1K09F3G675 | ENALAPRIL MALEATE TABLET [TARO PHARMACEUTICALS U.S.A., INC.] | 6 | |
| Ferric Oxide Yellow | INACTIVE INGREDIENT | EX438O2MRT | ENALAPRIL MALEATE TABLET [TARO PHARMACEUTICALS U.S.A., INC.] | 6 | |
| Lactose Monohydrate | INACTIVE INGREDIENT | EWQ57Q8I5X | ENALAPRIL MALEATE TABLET [TARO PHARMACEUTICALS U.S.A., INC.] | 6 | |
| Magnesium Stearate | INACTIVE INGREDIENT | 70097M6I30 | ENALAPRIL MALEATE TABLET [TARO PHARMACEUTICALS U.S.A., INC.] | 6 | |
| Sodium Bicarbonate | INACTIVE INGREDIENT | 8MDF5V39QO | ENALAPRIL MALEATE TABLET [TARO PHARMACEUTICALS U.S.A., INC.] | 6 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Enalapril Maleate | ENALAPRIL MALEATE | Coupler LLC | 508a58fa-9f66-e984-e063-6394a90a296a | 2026-04-28 | Boxed warning, Warnings, Adverse reactions | 858817 9O25354EPJ |
| Caldesene Baby | STARCH, CORN AND ZINC OXIDE | Insight Pharmaceuticals LLC | 9f12dee2-7afa-45e9-a729-0fd42bb77715 | 2026-04-22 | Warnings | O8232NY3SJ |
| Caldesene Medicated Protecting | CORNSTARCH AND ZINC OXIDE | Insight Pharmaceuticals LLC | ffc92a0f-a7cf-4a46-b2f1-089df2bbb96b | 2026-04-22 | Warnings | O8232NY3SJ |
| Arm and Hammer Baking Soda | SODIUM BICARBONATE | Church & Dwight Co., Inc. | 643fe204-4a7b-00e4-e053-2a91aa0aef06 | 2026-04-21 | Warnings | 8MDF5V39QO |
| SODIUM BICARBONATE | SODIUM BICARBONATE | Medical Purchasing Solutions, LLC | 4f97d398-2118-0874-e063-6394a90a4ad1 | 2026-04-16 | Warnings, Adverse reactions | 8MDF5V39QO |
| PEG 3350 and Electrolytes | POLYETHYLENE GLYCOL 3350, SODIUM SULFATE ANHYDROUS, SODIUM BICARBONATE, SODIUM CHLORIDE, POTASSIUM CHLORIDE | Wilshire Pharmaceuticals, Inc. | b251752d-7750-482a-9364-0acf4ad47cc8 | 2026-04-16 | Warnings, Adverse reactions | 8MDF5V39QO |
| GoLYTELY | POLYETHYLENE GLYCOL 3350, SODIUM SULFATE ANHYDROUS, SODIUM BICARBONATE, SODIUM CHLORIDE, POTASSIUM CHLORIDE | Azurity Pharmaceuticals, Inc. | 7609ecf7-0ce0-4fbb-9c27-30987f689575 | 2026-04-15 | Warnings, Adverse reactions | 8MDF5V39QO |
| TRILYTE | POLYETHYLENE GLYOCOL 3350, SODIUM CHLORIDE, SODIUM BICARBONATE AND POTASSIUM CHLORIDE | Aurobindo Pharma Limited | 79f5e596-8d51-4227-afcc-f5e341150957 | 2026-04-15 | Warnings, Adverse reactions | 8MDF5V39QO |
| PEG 3350, sodium chloride, sodium bicarbonate and potassium chloride | POLYETHYLENE GLYCOL 3350, SODIUM CHLORIDE, SODIUM BICARBONATE, POTASSIUM CHLORIDE | Wilshire Pharmaceuticals, Inc. | 4e442a72-b13b-4869-8a1d-59356095b091 | 2026-04-14 | Warnings, Adverse reactions | 8MDF5V39QO |
| Sodium Bicarbonate 10 gr. (650 mg) | SODIUM BICARBONATE | Gendose Pharmaceuticals, LLC | 0a0cc46d-372e-4175-932a-065e82d8d353 | 2026-04-13 | Warnings | 8MDF5V39QO |
| Enalapril Maleate | ENALAPRIL MALEATE | Preferred Pharmaceuticals Inc. | 5596ba00-4a1c-4503-99db-3a9617ed17c0 | 2026-04-10 | Boxed warning, Warnings, Adverse reactions | 858813 9O25354EPJ |
| Enalapril Maleate | ENALAPRIL MALEATE | Preferred Pharmaceuicals Inc. | 898b36d6-320f-4d6c-9734-0be8363dc3d7 | 2026-04-10 | Boxed warning, Warnings, Adverse reactions | 858817 9O25354EPJ |
| Enalapril Maleate | ENALAPRIL MALEATE | Preferred Pharmaceuticals Inc. | 9e277302-6e6c-4a95-8f25-aaff64fb0b82 | 2026-04-10 | Boxed warning, Warnings, Adverse reactions | 858810 9O25354EPJ |
| Calamine | CALAMINE 8%, ZINC OXIDE 8% | Farmacias De Similares TX LLC | 4ecd0add-11c9-cf3b-e063-6394a90adff6 | 2026-04-06 | Warnings | 1K09F3G675 |
| Sodium Bicarbonate | SODIUM BICARBONATE | Hospira, Inc. | ea9f4498-0d43-4043-8dd1-f22537841c21 | 2026-04-06 | Warnings, Adverse reactions | 8MDF5V39QO |
| Sodium Bicarbonate | SODIUM BICARBONATE | Hospira, Inc. | 8664c7ce-707b-4c6c-9ce4-7160b5f877f8 | 2026-04-06 | Warnings, Adverse reactions | 8MDF5V39QO |
| Omeprazole/Bicarbonate | OMEPRAZOLE AND SODIUM BICARBONATE | Proficient Rx LP | 4d642036-7175-4f29-9f07-dbd282231d4a | 2026-04-01 | Warnings, Adverse reactions | 8MDF5V39QO |
| Rapidol Sodium Bicarbonate | SODIUM BICARBONATE | Pharmadel LLC | b4c9a653-6f51-7c98-e053-2995a90ada37 | 2026-03-26 | Warnings | 8MDF5V39QO |
| Sodium Bicarbonate Antacid | SODIUM BICARBONATE | Aphena Pharma Solutions - Tennessee, LLC | bba7d5bf-c94b-4ee4-a399-9a2818d84c78 | 2026-03-23 | Warnings | 8MDF5V39QO |
| Powder | TITANIUM DIOXIDE | Oxygen Development LLC | 4d3a0a92-b0de-a1ea-e063-6294a90a8508 | 2026-03-17 | Warnings | 1K09F3G675 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.